Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
William D SchlaffRonald T AckermanAyman Al-HendyDavid F ArcherKurt T BarnhartLinda D BradleyBruce R CarrEve C FeinbergSandra M HurtadoJinHee KimRan LiuR Garn MabeyCharlotte D OwensAlfred PoindexterElizabeth E PuscheckHenry Rodriguez-GinorioJames A SimonAhmed M SolimanElizabeth A StewartNelson B WattsOzgul Muneyyirci-DelalePublished in: The New England journal of medicine (2020)
Elagolix with add-back therapy was effective in reducing heavy menstrual bleeding in women with uterine fibroids. (Funded by AbbVie; Elaris UF-1 and Elaris UF-2 ClinicalTrials.gov numbers, NCT02654054 and NCT02691494.).